跳至主要内容
临床试验/NCT04030520
NCT04030520已完成不适用

Improving Uptake and Adherence to HIV Prevention Services With PrEP, HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in Kampala, Uganda

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年7月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Adherence to PrEP

研究概览

简要总结

The main aim is to develop and assess an intervention to enhance initiation and adherence to PrEP among HIV negative young women of high risk (YWHR). The specific aims are (1) To conduct formative research to enhance our understanding of the dynamics of the social and sexual networks, and context of young HIV-uninfected women (aged 15-24) engaged in high risk sexual behavior in Kampala, Uganda (2) Document barriers and opportunities for PrEP uptake and adherence as well as repeat HIV testing by self test; (3) To develop and test a socially and culturally acceptable and feasible prevention intervention on uptake and adherence to PrEP and HIV self-testing for young women at high risk for HIV.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
15 Years 至 24 Years(Child, Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Female age 15- to 24-years old
  • •Engaging in high-risk sexual behavior having had sex at least once in last three months, --HlV-negative
  • •Agree to participate in a minimum of four interviews over a 12-month period; including baseline
  • •Willing to receive services at Good Health for Women Project (GHWP)
  • •For those initiating PrEP (Truvada):
  • •Participants should have immunity to Hepatitis B infection and serum creatinine before
  • •Contra-indications for starting Truvada to be considered include Creatinine > 1.2 ( (mgldl) or 0.106 (mmolil) and a weight below 35kg.

排除标准

  • •Inability to consent to participation in the study
  • •Condition impeding participation in the study, including severe mental reason to the discretion of the principal investigator, cognitive impairment or illness; serious medical illness or developmental disability and any other reason to the discretion of the principal investigator.

研究组 & 干预措施

intervention

Experimental

participants will receive a behavioral intervention including counseling and offer of HIV oral fluid self test and PrEP

干预措施: POPPi (Behavioral)

comparison

Active Comparator

participants will be not be offered HIV oral fluid self test but receive counseling, condoms and offered PrEP

干预措施: Comparison (Behavioral)

结局指标

主要结局

Adherence to PrEP

时间窗: 12 months

Adherence to PrEP using hair analysis measured by the concentration of antiretroviral drug in strands of hair. The results will be measured per participant using concentration in nanograms/milligrams. The number of participants who showed a positive drug concentration in nanograms/milligrams is reported.

Initiation of PrEP

时间窗: 6 months

Initiation of PrEP using the pharmacy records indicating PrEP received by participants.

Initiation of PrEP

时间窗: 6 months

Initiation of PrEP using the pharmacy records indicating PrEP received by participants.

Adherence to PrEP

时间窗: 12 months

Adherence to PrEP using hair analysis measured by the concentration of antiretroviral drug in strands of hair. The results will be measured per participant using concentration in nanograms/milligrams. The number of participants who showed a positive drug concentration in nanograms/milligrams is reported.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Improving Uptake and Adherence to HIV Prevention... | 临床试验